ImageneBio IMA
NASDAQ IMA
$4.05 -0.04 (-0.98%)
At close: Oct 22, 2026 · 4:00 PM EDT

ImageneBio (IMA) Price to Sales (2021 - 2025)

Updated

ImageneBio's Price to Sales came in at 16.16 for Q3 2025, up 42.2% from 11.36 a year earlier and up 23.9% from the prior quarter.

Analysis

ImageneBio (IMA) Price to Sales (2021 - 2025) Analysis & Trends

For FY2023, ImageneBio's Price to Sales was 10.38, up 68.1% from FY2022.

  • Going back by year, Price to Sales was 6.17 in FY2022 (-45.5%) and 11.32 in FY2021.
  • The Q3 2025 figure represents the highest quarterly Price to Sales since Q3 2021.
  • The fastest year-over-year change in Price to Sales over five years came in Q3 2023 (growth of 223.1%), and the weakest in Q3 2022 (a decline of 89.9%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 ImageneBio 34.53 Mn -453.09 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 16.16
Jun 30, 2025 13.04
Mar 31, 2025 10.05
Sep 30, 2024 11.36
Dec 31, 2023 10.38
Sep 30, 2023 13.69
Jun 30, 2023 14.48
Mar 31, 2023 7.13
Dec 31, 2022 6.17
Sep 30, 2022 4.24
Jun 30, 2022 5.79
Mar 31, 2022 7.13
Dec 31, 2021 11.32
Sep 30, 2021 41.79
Jun 30, 2021 50.77
Mar 31, 2021 11.52
API Access

ImageneBio Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=IMA&period=max&api_key=YOUR_API_KEY